4Parsons JK, Hergan LA, Sakamoto K, et al. Efficacy of alphablockers for the treatment of ureteral stones [J].J Urol, 2007, 177(3) : 983-987.
5Hollingsworth JM, Rogers MA, Kaufman SR, et al. Medical therapy to facilitate urinary stone passage: a meta-analysis[J]. Lancet, 2006, 368(9542):1171-1179.
6Sigala S, dellabella M, Milanese G, et al. Evidence for the presence of alphal adrenoceptor subtypes in the human ureter [J]. Neurourol Urodyn, 2005, 24(2):142-148.
7Yilmaz E, Batislam E, Basar MM, et al. The comparison and efficacy of 3 different alphal-adrenergic blockers for distal ureteral stones [J]. J Urol, 2005, 173(6):2010-2012.
8Erturhan S, Erbagci A, Yagci F, et al. Comparative evaluation of efficacy of use of tamsulosin and/or tolterodine for medical treatment of distal ureteral stones [J]. Urology, 2007, 69 (4) : 633-636.
9Gravas S, Tzortzis V, Karatzas A, et al. The use of tamsulozin as adjunctive treatment after ESWL in patients with distal ureteral stone: do we really need it? Results from a randomised study [J].Urol Res, 2007, 35(5) :231-235.
10Ahmad M, Chaughtai MN, Khan FA. Role of prostaglandin synthesis inhibitors in the passage of ureteric calculus[J]. J Pak Med Assoc, 1991, 41(11) :268-270.
